MENU
YMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Y-mAbs Therapeutics (YMAB) Earnings Date & Reports

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

YMAB is expected to report earnings to rise 130.83% to -27 cents per share on November 06

Y-mAbs Therapeutics YMAB Stock Earnings Reports
Q3'25
Est.
$-0.28
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.03
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.09
The last earnings report on May 13 showed earnings per share of -11 cents, beating the estimate of -19 cents. With 683.58K shares outstanding, the current market capitalization sits at 387.14M.
View a ticker or compare two or three
YMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. YMAB showed earnings on May 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com